pharmacoepidemiology

phar·ma·co·ep·i·dem·i·ol·o·gy

(far'mă-kō-ep'i-dē'mē-ol'ŏ-jē),
The study of the distribution and determinants of drug-related events in populations, and the application of this study to efficacious drug treatment.

phar·ma·co·ep·i·dem·i·ol·o·gy

(fahr'mă-kō-ep'i-dē'mē-ol'ŏ-jē)
The application of epidemiologic knowledge, methods, and reasoning to the study of the effects and uses of pharmacologic treatments in a defined time, space, and population.
See also: epidemiology, pharmacology

pharmacoepidemiology

(făr′mă-kō-ĕ-pĭ-dĕm-ē-ŏl″ō-jē)
The application of the science of epidemiology to the study of the effects of drugs, desired and undesired, and uses of drugs in human populations.

pharmacoepidemiology

the study of the utilization and effects of drugs in large numbers of patients.
Mentioned in ?
References in periodicals archive ?
van Staa, also of the department of pharmacoepidemiology and pharmacotherapy, University of Utrecht (the Netherlands).
After 1 year of steroid therapy, one in six women have fractures. (Without Bisphosphonate Therapy)
Solomon, director of health services research in the division of pharmacoepidemiology and pharmacoeconomics at Brigham and Women's Hospital, Boston.
Osteoporosis medications called 'vastly underused'. (Only 20% Got TX After Hip Fracture)
Pharmacoepidemiology and Drug Safety , pulled data from the weeklong online medication diary entries of more than 1,300 people to learn just how many went over the limit.
You're Probably Taking Too Much Ibuprofen, Study Says
Results were published in Pharmacoepidemiology and Drug Safety.
Xarelto (rivaroxaban) Safety, Effectiveness, and Association with Lower Risk of Ischemic Stroke vs. Warfarin Confirmed by US FDA Mini-Sentinel Assessment
Healthcare company Janssen Pharmaceutical Companies onTuesday updated and published the positive findings from the US Food and Drug Administration (FDA) Mini-Sentinel pilot project assessment of XARELTO (rivaroxaban) under the phase III ROCKET AF clinical trials in Pharmacoepidemiology & Drug Safety.
Janssen provides update of US FDA Mini-Sentinel Assessment of XARELTO (rivaroxaban) for lowering risk of ischemic stroke
Food and Drug Administrations (FDA) Mini-Sentinel assessment, confirming the positive safety and efficacy profile of XARELTO (rivaroxaban) established in the phase III ROCKET AF clinical trials, were published in Pharmacoepidemiology & Drug Safety.
United States : FDA Mini-Sentinel Assessment Confirms Safety and Effectiveness of XARELTO (rivaroxaban) and its Association with a Lower Risk of Ischemic Stroke vs. Warfarin
Study author Elisabetta Patorno from BWH Division of Pharmacoepidemiology & Pharmacoeconomics said the results suggest that the increased risk of oral clefts is most pronounced in women taking higher doses of Topiramate to treat epilepsy.
Taking Topiramate in pregnancy ups oral cleft risk in babies

Medical browser ?
Full browser ?